Lakibol, Bb Boy .
HRN: 23-00-98 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
05/09/2023
05/16/2023
IV
20mg
Q24
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes